A Texas state judge on November 14, 2025 ruled that Kenvue, the former Johnson & Johnson spin‑off, may proceed with its scheduled $398 million dividend payment due on November 26. The decision came after Texas Attorney General Ken Paxton filed a lawsuit seeking to block the distribution, arguing that the company had concealed risks associated with Tylenol use during pregnancy that could lead to autism and ADHD in children.
Continue reading for full analysis...
Ken Paxton, Texas’s attorney general, filed a motion with a state court to stop Kenvue’s planned dividend of $398 million that was scheduled to be paid on November 26, 2025. The motion cites the state’s lawsuit, filed on October 28, 2025, which accuses Kenvue of concealing risks associated with Tylenol use during pregnancy that could lead to autism and ADHD in children.
Continue reading for full analysis...